LEIOMYOSARCOMA OF OVARY

Clinical trials for LEIOMYOSARCOMA OF OVARY explained in plain language.

Never miss a new study

Get alerted when new LEIOMYOSARCOMA OF OVARY trials appear

Sign up with your email to follow new studies for LEIOMYOSARCOMA OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New trial tests which drug better controls aggressive cancer

Disease control Recruiting now

This study compares two cancer drugs, trabectedin and gemcitabine, to see which works better for controlling advanced leiomyosarcoma after initial chemotherapy has stopped working. It will enroll 100 adults whose cancer has progressed despite previous treatment. The trial include…

Matched conditions: LEIOMYOSARCOMA OF OVARY

Phase: PHASE2 • Sponsor: Italian Sarcoma Group • Aim: Disease control

Last updated Mar 23, 2026 15:29 UTC

LEIOMYOSARCOMA OF OVARY

Get alerted when new LEIOMYOSARCOMA OF OVARY trials appear

New trial tests which drug better controls aggressive cancer